Trends in life expectancy among medical aid beneficiaries and National Health Insurance beneficiaries in Korea between 2004 and 2017.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
19 Aug 2019
Historique:
received: 29 04 2019
accepted: 14 08 2019
entrez: 21 8 2019
pubmed: 21 8 2019
medline: 7 11 2019
Statut: epublish

Résumé

Medical Aid beneficiaries in Korea are more likely to have poor health status and to receive insufficient healthcare services, but their life expectancy has not been compared with that of National Health Insurance beneficiaries. We used the National Health Information Database in Korea to obtain aggregate data on the numbers of population and deaths according to calendar year (2004 to 2017), sex, age group, and insurance eligibility (Medical Aid or National Health Insurance). Between 2004 and 2017, a summed total of 697,503,634 subjects (combining numbers of subjects for 14 years) and 3,536,778 deaths, including 22,417,216 Medical Aid beneficiaries and 499,604 associated deaths, were used to construct annual abridged life tables. In 2017, the life expectancy of Medical Aid beneficiaries was 70.9 years, while that of National Health Insurance beneficiaries was 83.7 years. Between 2004 and 2017, life expectancy for Medical Aid beneficiaries increased by 8.7 years in men and 6.1 years in women, while life expectancy for National Health Insurance beneficiaries increased by 5.2 years in men and 4.5 years in women. The life expectancy difference between National Health Insurance beneficiaries and Medical Aid beneficiaries was especially great among men across all study periods. The life expectancy difference was 15.8 years for men and 8.9 years for women in 2017. The life expectancy of Medical Aid beneficiaries was shorter than that of National Health Insurance beneficiaries. The government should implement policies to deliver more adequate health care to Medical Aid beneficiaries.

Sections du résumé

BACKGROUND BACKGROUND
Medical Aid beneficiaries in Korea are more likely to have poor health status and to receive insufficient healthcare services, but their life expectancy has not been compared with that of National Health Insurance beneficiaries.
METHODS METHODS
We used the National Health Information Database in Korea to obtain aggregate data on the numbers of population and deaths according to calendar year (2004 to 2017), sex, age group, and insurance eligibility (Medical Aid or National Health Insurance). Between 2004 and 2017, a summed total of 697,503,634 subjects (combining numbers of subjects for 14 years) and 3,536,778 deaths, including 22,417,216 Medical Aid beneficiaries and 499,604 associated deaths, were used to construct annual abridged life tables.
RESULTS RESULTS
In 2017, the life expectancy of Medical Aid beneficiaries was 70.9 years, while that of National Health Insurance beneficiaries was 83.7 years. Between 2004 and 2017, life expectancy for Medical Aid beneficiaries increased by 8.7 years in men and 6.1 years in women, while life expectancy for National Health Insurance beneficiaries increased by 5.2 years in men and 4.5 years in women. The life expectancy difference between National Health Insurance beneficiaries and Medical Aid beneficiaries was especially great among men across all study periods. The life expectancy difference was 15.8 years for men and 8.9 years for women in 2017.
CONCLUSIONS CONCLUSIONS
The life expectancy of Medical Aid beneficiaries was shorter than that of National Health Insurance beneficiaries. The government should implement policies to deliver more adequate health care to Medical Aid beneficiaries.

Identifiants

pubmed: 31426770
doi: 10.1186/s12889-019-7498-2
pii: 10.1186/s12889-019-7498-2
pmc: PMC6701124
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1137

Subventions

Organisme : Korea Health Industry Development Institute
ID : HI18C0446
Pays : Republic of Korea

Références

J Prev Med Public Health. 2005 Feb;38(1):93-100
pubmed: 16312914
J Prev Med Public Health. 2007 Jan;40(1):51-8
pubmed: 17310599
Soc Work Public Health. 2010 Mar;25(2):210-22
pubmed: 20391262
J Korean Med Sci. 2012 May;27 Suppl:S70-5
pubmed: 22661875
N Engl J Med. 2012 Sep 13;367(11):1025-34
pubmed: 22830435
Public Health. 2013 Sep;127(9):806-13
pubmed: 23434039
Hypertens Res. 2013 Nov;36(11):1000-5
pubmed: 23966057
Asian Pac J Cancer Prev. 2013;14(11):6919-24
pubmed: 24377626
BMJ Qual Saf. 2014 Sep;23(9):741-8
pubmed: 24608101
Ann Intern Med. 2014 May 6;160(9):585-93
pubmed: 24798521
J Prev Med Public Health. 2004 Aug;37(3):267-73
pubmed: 25175473
Health Policy. 2015 May;119(5):680-7
pubmed: 25456018
Eur J Public Health. 2016 Apr;26(2):242-8
pubmed: 26136463
Int J Environ Res Public Health. 2015 Nov 13;12(11):14571-88
pubmed: 26580643
Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
J Epidemiol. 2017 Jun;27(6):258-264
pubmed: 28314637
Int J Environ Res Public Health. 2017 Apr 21;14(4):
pubmed: 28430143
Am J Public Health. 2018 Apr;108(4):565-567
pubmed: 29346003
BMJ Open. 2018 Jun 30;8(6):e020280
pubmed: 29961008
PLoS One. 2018 Oct 29;13(10):e0206374
pubmed: 30372481
Cancer Res Treat. 2019 Jul;51(3):1241-1248
pubmed: 30653747

Auteurs

Jinwook Bahk (J)

Department of Public Health, Keimyung University, 1095, Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.

Hee-Yeon Kang (HY)

Department of Health Policy and Management, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.

Young-Ho Khang (YH)

Department of Health Policy and Management, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. yhkhang@snu.ac.kr.
Institute of Health Policy and Management, Seoul National University Medical Research Center, 103 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. yhkhang@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH